EpiBone
Born and raised in Thailand, Sarindr (a.k.a. Ik) moved to the U.S. to pursue science. His Ph.D. and postdoc at Columbia University focused on engineering bone, cartilage, and osteochondral tissues from stem cells. Now he works to translate that innovation toward clinical use here at EpiBone. Sarindr holds two patents and has authored four book chapters and more than 15 journal articles related to bone and cartilage tissue engineering. He enjoys rock climbing, snowboarding, & soccer.
EpiBone
3 followers
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.